Large-scale testing (Phase 3)UnknownNCT01094340What this trial is testingThalidomide for Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Banner Health 20
Not applicableStudy completedNCT00211159What this trial is testingOmegAD (Omega-3 and Alzheimer's Disease)Who this might be right forAlzheimer's Disease Karolinska University Hospital 204
Testing effectiveness (Phase 2)Study completedNCT01350362What this trial is testingEfficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease PatientsWho this might be right forAlzheimer's Disease Noscira SA 306
Early research (Phase 1)Study completedNCT02624778What this trial is testingLY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or ADWho this might be right forAlzheimer Disease Eli Lilly and Company 61
Testing effectiveness (Phase 2)Ended earlyNCT01676935What this trial is testingThis is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease AbbVie (prior sponsor, Abbott) 349
Testing effectiveness (Phase 2)Study completedNCT00948259What this trial is testingSafety Study of a Glycogen Synthase Kinase 3 (GSK3) Inhibitor in Patients With Alzheimer´s DiseaseWho this might be right forAlzheimer´s Disease Noscira SA 30
Testing effectiveness (Phase 2)Ended earlyNCT00960531What this trial is testingA Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Pfizer 160
Testing effectiveness (Phase 2)Study completedNCT03748706What this trial is testingPTI-125 for Mild-to-moderate Alzheimer's Disease PatientsWho this might be right forAlzheimer Disease Pain Therapeutics 13
Testing effectiveness (Phase 2)Ended earlyNCT00606476What this trial is testingAAB-001 (Bapineuzumab) Open-Label, Long-Term Extension Study in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease JANSSEN Alzheimer Immunotherapy Research & Development, LLC 194
Testing effectiveness (Phase 2)UnknownNCT00174525What this trial is testingSafety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pharmacology Research Institute
Not applicableStudy completedNCT04570215What this trial is testingDigital Interventions in Neuro-Rehabilitation: Gotcha!Who this might be right forDementiaAlzheimer DiseaseAnomia University College, London 48
Large-scale testing (Phase 3)Study completedNCT05686044What this trial is testingA Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADWho this might be right forAlzheimer Disease Annovis Bio Inc. 351
Not applicableStudy completedNCT01937221What this trial is testingNovel Retinal Imaging Biomarkers in Early Alzheimer's DiseaseWho this might be right forMild Cognitive ImpairmentMild to Moderate Cognitive Impairment Duke University 60
Large-scale testing (Phase 3)Study completedNCT02079246What this trial is testingLong-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease H. Lundbeck A/S 1,463
Not applicableStudy completedNCT01825317What this trial is testingEffect of NeuroAD on Alzheimer PatientsWho this might be right forAlzheimer's Disease Neuronix Ltd 32
Large-scale testing (Phase 3)Ended earlyNCT01969136What this trial is testingStudy of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseWho this might be right forAlzheimer's DiseaseDementia FORUM Pharmaceuticals Inc 403
Large-scale testing (Phase 3)Study completedNCT02585934What this trial is testingStudy Evaluating Intepirdine (RVT-101) in Subjects With Mild to Moderate Alzheimer's Disease on Donepezil: MINDSET StudyWho this might be right forAlzheimer's Disease Axovant Sciences Ltd. 1,315
Not applicableNot Yet RecruitingNCT07673263What this trial is testingEffects of X Box Kinect 360 in Alzheimer's DiseaseWho this might be right forAlzheimer s Disease Ziauddin University 38
Early research (Phase 1)Ended earlyNCT02220738What this trial is testingStudy to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsWho this might be right forAlzheimer's Disease AbbVie 19
Testing effectiveness (Phase 2)Ended earlyNCT00334568What this trial is testingEffects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 12